Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group studyG Aravantinos, D V Skarlos, P Kosmidis, et al.
Health Physics|January 1, 1989
Radiocesium levels measured in breast milk one year after the reactor accident at ChernobylP A Assimakopoulos, K G Ioannides, A A Pakou, et al.
European Journal of Gynaecological Oncology|August 15, 2001
Replacement of the uterus by malignant mesothelioma of the peritoneum: a case reportV Dousias, S Chouliara, C Zioga, et al.
Clinical Endocrinology|February 1, 1993
Changes in pituitary response to GnRH during the luteal-follicular transition of the human menstrual cycleI E Messinis, D Koutsoyiannis, S Milingos, et al.
Clinical Endocrinology|February 1, 1996
Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycleI E Messinis, D Lolis, K Zikopoulos, et al.
Fetal Diagnosis and Therapy|January 1, 1995
Clinical significance of creatine kinase isoenzymes for fetal asphyxia in women at laborS Andronikou, E Bairaktari, A D Vasiliadou, et al.
Human Reproduction (Oxford, England)|February 1, 1994
Effect of follicle stimulating hormone treatment on the pituitary response to luteinizing hormone-releasing hormone in post-menopausal womenI E Messinis, D Lolis, L Papastergiopoulou, et al.
Clinical Endocrinology|July 1, 1993
Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in womenI E Messinis, D Lolis, L Papadopoulos, et al.
Gynecologic Oncology|June 30, 2000
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter studyM A Dimopoulos, C A Papadimitriou, V Georgoulias, et al.
Maturitas|November 1, 1995
Prevention of post-oophorectomy bone loss with TiboloneG P Lyritis, S Karpathios, K Basdekis, et al.
Pageof 15